ARID1B loss remodels the chromatin landscape to promote sorafenib resistance in hepatocellular carcinoma
ChIP-seq / ATAC-seq (genome binding and open chromatin) · human · 80 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Homo sapiens (human)
- Topic
- Hepatocellular carcinomaThis series is part of our curated briefing on it.
- Samples
- 80 samples: 40 conditions, mostly in duplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE335770_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1479419 and SRA study SRP710416. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 80 samples.
How we read this: 40 replicated groups read from 80 sample titles; they account for 80 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9820485 HepG2 WT H3K27ac CUT&RUN, DMSO, rep1 HepG2 WT H3K27ac CUT&RU…
- GSM9820486 HepG2 WT H3K27ac CUT&RUN, DMSO, rep2 HepG2 WT H3K27ac CUT&RU…
- GSM9820487 HepG2 WT H3K4me3 CUT&RUN, DMSO, rep1 HepG2 WT H3K4me3 CUT&RU…
- GSM9820488 HepG2 WT H3K4me3 CUT&RUN, DMSO, rep2 HepG2 WT H3K4me3 CUT&RU…
- GSM9820489 HepG2 WT ARID1B CUT&RUN, DMSO, rep1 HepG2 WT ARID1B CUT&RUN…
- GSM9820490 HepG2 WT ARID1B CUT&RUN, DMSO, rep2 HepG2 WT ARID1B CUT&RUN…
- GSM9820491 HepG2 WT IgG CUT&RUN, DMSO, rep1 HepG2 WT IgG CUT&RUN, D…
- GSM9820492 HepG2 WT IgG CUT&RUN, DMSO, rep2 HepG2 WT IgG CUT&RUN, D…
- GSM9820493 HepG2 WT H3K27ac CUT&RUN, Sorafenib, rep1 HepG2 WT H3K27ac CUT&RU…
- GSM9820494 HepG2 WT H3K27ac CUT&RUN, Sorafenib, rep2 HepG2 WT H3K27ac CUT&RU…
- GSM9820495 HepG2 WT H3K4me3 CUT&RUN, Sorafenib, rep1 HepG2 WT H3K4me3 CUT&RU…
- GSM9820496 HepG2 WT H3K4me3 CUT&RUN, Sorafenib, rep2 HepG2 WT H3K4me3 CUT&RU…
- GSM9820497 HepG2 WT ARID1B CUT&RUN, Sorafenib, rep1 HepG2 WT ARID1B CUT&RUN…
- GSM9820498 HepG2 WT ARID1B CUT&RUN, Sorafenib, rep2 HepG2 WT ARID1B CUT&RUN…
- GSM9820499 HepG2 WT IgG CUT&RUN, Sorafenib, rep1 HepG2 WT IgG CUT&RUN, S…
- GSM9820500 HepG2 WT IgG CUT&RUN, Sorafenib, rep2 HepG2 WT IgG CUT&RUN, S…
- GSM9820501 HepG2 ARID1B-KO H3K27ac CUT&RUN, DMSO, rep1 HepG2 ARID1B-KO H3K27ac…
- GSM9820502 HepG2 ARID1B-KO H3K27ac CUT&RUN, DMSO, rep2 HepG2 ARID1B-KO H3K27ac…
- GSM9820503 HepG2 ARID1B-KO H3K4me3 CUT&RUN, DMSO, rep1 HepG2 ARID1B-KO H3K4me3…
- GSM9820504 HepG2 ARID1B-KO H3K4me3 CUT&RUN, DMSO, rep2 HepG2 ARID1B-KO H3K4me3…
- GSM9820505 HepG2 ARID1B-KO ARID1B CUT&RUN, DMSO, rep1 HepG2 ARID1B-KO ARID1B …
- GSM9820506 HepG2 ARID1B-KO ARID1B CUT&RUN, DMSO, rep2 HepG2 ARID1B-KO ARID1B …
- GSM9820507 HepG2 ARID1B-KO IgG CUT&RUN, DMSO, rep1 HepG2 ARID1B-KO IgG CUT…
- GSM9820508 HepG2 ARID1B-KO IgG CUT&RUN, DMSO, rep2 HepG2 ARID1B-KO IgG CUT…
- GSM9820509 HepG2 ARID1B-KO H3K27ac CUT&RUN, Sorafenib, rep1 HepG2 ARID1B-KO H3K27ac…
- GSM9820510 HepG2 ARID1B-KO H3K27ac CUT&RUN, Sorafenib, rep2 HepG2 ARID1B-KO H3K27ac…
- GSM9820511 HepG2 ARID1B-KO H3K4me3 CUT&RUN, Sorafenib, rep1 HepG2 ARID1B-KO H3K4me3…
- GSM9820512 HepG2 ARID1B-KO H3K4me3 CUT&RUN, Sorafenib, rep2 HepG2 ARID1B-KO H3K4me3…
- GSM9820513 HepG2 ARID1B-KO ARID1B CUT&RUN, Sorafenib, rep1 HepG2 ARID1B-KO ARID1B …
- GSM9820514 HepG2 ARID1B-KO ARID1B CUT&RUN, Sorafenib, rep2 HepG2 ARID1B-KO ARID1B …
- GSM9820515 HepG2 ARID1B-KO IgG CUT&RUN, Sorafenib, rep1 HepG2 ARID1B-KO IgG CUT…
- GSM9820516 HepG2 ARID1B-KO IgG CUT&RUN, Sorafenib, rep2 HepG2 ARID1B-KO IgG CUT…
- GSM9820517 HLF WT H3K27ac CUT&RUN, DMSO, rep1 HLF WT H3K27ac CUT&RUN,…
- GSM9820518 HLF WT H3K27ac CUT&RUN, DMSO, rep2 HLF WT H3K27ac CUT&RUN,…
- GSM9820519 HLF WT H3K4me3 CUT&RUN, DMSO, rep1 HLF WT H3K4me3 CUT&RUN,…
- GSM9820520 HLF WT H3K4me3 CUT&RUN, DMSO, rep2 HLF WT H3K4me3 CUT&RUN,…
- GSM9820521 HLF WT ARID1B CUT&RUN, DMSO, rep1 HLF WT ARID1B CUT&RUN, …
- GSM9820522 HLF WT ARID1B CUT&RUN, DMSO, rep2 HLF WT ARID1B CUT&RUN, …
- GSM9820523 HLF WT FOXA1 CUT&RUN, DMSO, rep1 HLF WT FOXA1 CUT&RUN, D…
- GSM9820524 HLF WT FOXA1 CUT&RUN, DMSO, rep2 HLF WT FOXA1 CUT&RUN, D…
+ 40 more — browse all 80 samples with per-sample file links →
- GSE109211 Molecular predictors of prevention of recurrence in hepatocellular carcinoma with sorafenib as adjuvant treatment in the phase 3 STORM trial 140 samples same disease briefing · shares hepatocellular, sorafenib
- GSE14520 Gene expression data of human hepatocellular carcinoma (HCC) 488 samples same disease briefing · shares hepatocellular
- GSE10143 Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma 387 samples same disease briefing · shares hepatocellular
- GSE107170 Molecular Signature of Hepatitis D Virus-Associated Hepatocellular Carcinoma 307 samples same disease briefing · shares hepatocellular
- GSE10186 Integrative Transcriptome Analysis Reveals Common Molecular Subtypes of Human Hepatocellular Carcinoma 118 samples same disease briefing · shares hepatocellular
- GSE105130 Comprehensive analysis of Transcriptome Profiles in Hepatocellular Carcinoma patients 52 samples same disease briefing · shares hepatocellular
- GSE140228 Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma 41 samples same disease briefing · shares hepatocellular
- GSE114564 Identification of novel serum biomarkers in early-stage HCC patients. 118 samples same disease briefing
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.